| | Business Summary | | Apogent
Technologies,
Inc.,
formerly
known
as
Sybron
International
Corp.,
through
its
subsidiaries,
designs,
manufactures
and
markets
value-added
laboratory
and
life
science
products
for
the
clinical,
research
and
industrial
markets,
worldwide.
The
Company's
lines
of
business
include
Labware
and
Life
Sciences,
Diagnostics
and
Microbiology,
Clinical
and
Industrial,
and
Laboratory
Equipment.
In
December
2000,
the
Company
spun-off
Sybron
Dental
Specialties
into
an
independent
publicly
traded
company. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | AOT
manufactures
value-added
products
for
the
laboratory
market
(plastic
labware,
microscope
slides,
consumables)
and
professional
orthodontic
and
dental
markets
(orthodontic
appliances)
in
the
U.S.
and
overseas.
For
the
nine
months
ended
6/30/01,
sales
rose
14%
to
$726.3
million.
Net
income
before
extraordinary
item
from
continuing
operations
rose
15%
to
$80.5
million.
Results
reflect
higher
sales
of
products
of
acquired
companies
and
a
favorable
gross
margin
variance. | | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Kenneth Yontz, 56
Chairman | $931K | Frank Jellinek, Jr., 55
Pres,
CEO, Director | 615K | Jeffrey Leathe, 44
CFO,
Exec. VP-Fin., Treasurer | -- | Michael Bresson, 42
Exec.
VP, Gen. Counsel, Sec. | -- | Mark Stuppy, 46
Exec.
VP of Sales and Marketing, Clinical Products | -- | | Dollar
amounts are as of 30-Sep-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/a/aot.gif)